NDC 70752-171

PROPYLTHIOURACIL

Propylthiouracil

PROPYLTHIOURACIL is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Quagen Pharmaceuticals Llc. The primary component is Propylthiouracil.

Product ID70752-171_d32ed2a1-db86-4000-a306-237a2f425fcb
NDC70752-171
Product TypeHuman Prescription Drug
Proprietary NamePROPYLTHIOURACIL
Generic NamePropylthiouracil
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2021-03-18
Marketing CategoryANDA /
Application NumberANDA080154
Labeler NameQUAGEN PHARMACEUTICALS LLC
Substance NamePROPYLTHIOURACIL
Active Ingredient Strength50 mg/1
Pharm ClassesThyroid Hormone Synthesis Inhibitor [EPC],Thyroid Hormone Synthesis Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 70752-171-10

100 TABLET in 1 BOTTLE (70752-171-10)
Marketing Start Date2021-03-18
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "PROPYLTHIOURACIL" or generic name "Propylthiouracil"

NDCBrand NameGeneric Name
0143-1480PropylthiouracilPropylthiouracil
0228-2348PropylthiouracilPropylthiouracil
0615-7583propylthiouracilpropylthiouracil
42254-010PropylthiouracilPropylthiouracil
67253-651PropylthiouracilPropylthiouracil
68084-964PropylthiouracilPropylthiouracil
70752-171PROPYLTHIOURACILPROPYLTHIOURACIL

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.